4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-21-000044
EVP, Chief Medical Officer acquired 5,883 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Smith Karen L. · EVP, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-24 | Grant or award : show line 1 in the form | +2,942 | 9,252 | D |
| 2021-02-24 | Grant or award : show line 2 in the form | +2,941 | 12,193 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-24 | Grant or award : show line 3 in the form Employee Stock Options (Right to Buy) | +11,765 | $93.49 | $1,099,910 | 11,765 | D |
Loading xslF345X03/wf-form4_161437771751742.xml…